Skip to content

Coronary Microvascular Dysfunction in Myocardial Infarction with Non-Obstructive Coronary Arteries

Evaluate the feasibility and diagnostic performance of Breathing-Induced Myocardial Oxygenation Reserve (B-MORE) oxygen-sensitive (OS) cardiac magnetic resonance imaging (CMR) to assess coronary microvascular dysfunction in myocardial infarction with non-obstructive coronary arteries (MINOCA).

Status
Not yet recruiting
Phases
Unknown
Study type
Interventional
Source
ANZCTR
Registry ID
ACTRN12626000185369
Acronym
MICRO-MI
Enrollment
60
Registered
2026-02-12
Start date
2026-04-01
Completion date
2030-11-30
Last updated
2026-03-02

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Brief summary

Most heart attacks are caused by blocked coronary arteries; however, some people, particularly women, experience a heart attack despite having no significant arterial blockages. This condition is known as MINOCA, or myocardial infarction with non-obstructive coronary arteries. Many individuals with MINOCA do not receive a clear explanation for their symptoms, and a substantial proportion continue to experience chest pain long after the initial event. We hypothesise that dysfunction of the heart’s small blood vessels, termed coronary microvascular dysfunction, may underlie these symptoms. Current methods to assess this condition are invasive and not routinely available. In this study, we will use a novel, non-invasive magnetic resonance imaging technique to assess how these small vessels respond to controlled changes in breathing. Findings from patients with MINOCA will be compared with those from individuals with myocardial infarction due to obstructive coronary artery disease, patients with hypertension, and healthy volunteers. This research aims to improve understanding and diagnosis of MINOCA by identifying a mechanism that is frequently overlooked.

Interventions

Study group : MINOCA – patients with myocardial infarction and non-obstructive coronary arteries. All participants will undergo Breathing-Induced Myocardial Oxygenation Reserve (B-MORE) oxygen-sensitive cardiac magnetic resonance imaging (OS-CMR) to assess myocardial oxygenation, enabling comparison across the four study groups. Device description The intervention will use a clinical whole-body 3 Tesla cardiac magnetic resonance imaging system equipped with standard multi-channel cardiac radio

Study group : MINOCA – patients with myocardial infarction and non-obstructive coronary arteries. All participants will undergo Breathing-Induced Myocardial Oxygenation Reserve (B-MORE) oxygen-sensitive cardiac magnetic resonance imaging (OS-CMR) to assess myocardial oxygenation, enabling comparison across the four study groups. Device description The intervention will use a clinical whole-body 3 Tesla cardiac magnetic resonance imaging system equipped with standard multi-channel cardiac radiofrequency coils. Oxygenation-sensitive imaging will be performed using a validated blood-oxygen-level–dependent (BOLD) CMR pulse sequence, which will be sensitive to changes in myocardial oxygenation and will not require ionising radiation or intravenous contrast administration. What participation will involve Participants will attend a single CMR study visit. Following routine MRI safety screening, participants will be positioned supine within the scanner. Standard cardiac localiser and cine sequences will be acquired, followed by oxygenation-sensitive imaging performed at rest and during a controlled hyperventilation manoeuvre. This will include baseline image acquisition, followed by a 60-second period of paced hyperventilation at a rate of 30 breaths per minute. Hyperventilation will be guided by a metronome delivered through the CMR speaker system. Immediately following hyperventilation, participants will perform a voluntary maximal breath-hold, during which oxygenation-sensitive CMR images will be continuously acquired until normal breathing is resumed. Participants will then rest and breathe normally for 180 seconds to allow physiological parameters to return to baseline. Following the recovery period, the breathing manoeuvre will be repeated in accordance with the same protocol. Duration and frequency The intervention will be performed once only. The total scan duration will be approximately 45 to 60 minutes. Who will deliver the intervention The CMR examination will be conducted by accredited cardiac MRI radiographers. The hyperventilation protocol will be supervised by trained clinical staff in accordance with institutional CMR procedures. Location/setting The intervention will be conducted within a hospital-based clinical MRI facility at Flinders Medical Centre, South Australia Adherence and fidelity monitoring Adherence to the intervention will be ensured by completion of the imaging protocol during the scheduled visit. Fidelity will be maintained through the use of a standardised OS-CMR acquisition protocol and a predefined hyperventilation procedure. Compliance with the hyperventilation manoeuvre will be monitored in real time by radiographers via direct communication with participants and review of respiratory pattern and image quality. Image datasets will be reviewed by experienced CMR investigators to confirm protocol adherence and adequacy of the physiological stress response.

Sponsors

Flinders University
Lead SponsorUniversity

Study design

Allocation
Non-randomised trial
Primary purpose
Diagnosis
Masking
Open (masking not used)

Eligibility

Sex/Gender
All
Age
18 Years to No maximum
Healthy volunteers
Yes

Inclusion criteria

1. Aged 18 years and over 2. Suspected MINOCA participants – as per the international diagnostic criteria (ref) 3. MI-CAD participants diagnosis of MI due to obstructive CAD. 4. Hypertensive participants [Diagnosed high blood pressure ± medical therapy and No history of MI, known CAD and/or heart failure] 5. The healthy group - will have no history of cardiovascular risk factors, including hypertension, diabetes, or hyperlipidemia and will be divided into two subgroups: a. participants aged under 35 years b. participants aged over 45 years ref- Tamis-Holland JE, Jneid H, Reynolds HR, Agewall S, Brilakis ES, Brown TM, Lerman A, Cushman M, Kumbhani DJ, Arslanian-Engoren C, et al. Contemporary Diagnosis and Management of Patients With Myocardial Infarction in the Absence of Obstructive Coronary Artery Disease: A Scientific Statement From the American Heart Association. Circulation. 2019;139:e891-e908. doi: 10.1161/cir.0000000000000670

Exclusion criteria

1. Previous MI or known CAD. 2. CMR incompatibilities (pacemaker, claustrophobia, implants). 3. Severe kidney function impairment (eGFR <30). 4. Other conditions that mimic MINOCA presentations (myocarditis, Takotsubo cardiomyopathy, spontaneous coronary artery dissection). – these exclusions may occur after CMR as CMR is the gold standard to reveal this diagnosis. 5. History of severe valvular/structural heart disease or arrhythmias.

Outcome results

None listed

Source: ANZCTR · Data processed: Mar 14, 2026